Bioavailability of oral drug formulations and methods for its improvement

Biomeditsinskaya Khimiya

Volumn 56, Issue 1, 2010, Pages 101-119

  Ipatova, O M ^a   Torkhovskaya, T I ^a   Medvedeva, N V ^a   Prozorovskiy, V N ^a   Ivanova, N D ^a   Shtronin, A V ^a   Buranova, V S ^a   Archakov, A I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Drug bioavailability; Drug formulations; Enterocytes; Intestinal absorption; Lymphatic transport; Paracellular absorption; Phospholipid nanoparticles

Indexed keywords

RATTUS;

EID: 77953012509     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: 10.18097/pbmc20105601101     Document Type: Article

References (74)

1. Martinez M. N., Amidon G. L. (2002) J. Clin. Pharmacol, 42(6), 620-643.
2. Arora S, Ali J., Ahuja A., Khar R. K., Baboota S. (2005) AAPS Pharm. Sci. Tech, 6(3), E372-E390.
3. Basarab GS., Hill P. J., Rastagar A., Webborn P. J. (2008) Bioorg. Med. Chem. Lett., 8(16), 4716-4722.
4. Cano-Cebrián M. J., Zornoza T., Granero L., Polache A. (2005) Curr. Drug Deliv,. 2(1), 9-22.
5. des Rieux A., Fievez V., Garinot M., Schneider Y. J., Préat V. (2006) J. Control Release, 116(1), 1-27.
6. Takano M.., Yumoto R... Murakami T. (2006)Pharmacol. Ther, 109(1-2), 137-161.
7. Zaĩer Z. M., Eloranta J. J., Stieger B., Kullak- Ublick G. A. (2008) Pharmacogenomics, 9(5), 597-624.
8. Kato M. (2008) Drug Metab. Pharmacokinet, 23(2), 87-94.
9. van de Kerkhof E. G., de Graaf I. A., Groothuis G. M. (2007) Curr. Drug Metab, 8(7), 658-675.
10. Porter C. J, Charman W. N. (2001) Adv Drug Deliv Rev, 50(1-2), 1-2.
11. Portel C. J., Patel G. C., Patel R. B., Patel S. S., Patel J. K., Bharadia P. D., Patel M. M. (2006) Drug Deliv. Technol, 6(7), 62-71.
12. Krishnaiah Y. S. R., Veer Raju P., Dinesh KB., Bhaskar P., Satyanarayana V (2001) J. Control Rel, 77, 87-95.
13. Chen K, Yu W. P., Song L, Zhu Y. M. (2005) World J. Gastroenterol, 11(5), 641-644.
14. Ruh J., Schmidt E., Vogel F. (2003) Dig. Dis. Sci, 48(5), 882-889.
15. Chen M., Yang Y, Braunstein E., Georgeson K. E., Harmon C. M. (2001) Am. J. Physiol. Endocrinol. Metab, 281(5), E916-E923.
16. Katneni K., Charman S. A., Porter C. J. (2008) J. Pharm .Pharmacol, 60(10), 1311-1319.
17. Marcus S. K., Schteingart C. D., Marquez M. L., Hofmann A. F., Xia Y, Steinbach J. H., Ton-Ku H. T., Lillienau J., Angellotti M. A., Schmassmann A. (1991) Gastroenterology, 100(1), 212-221.
18. Li J. P., Chang T. M., WagnerD., Chey W. Y. (2001) Am. J. Physiol. Gastrointest. Liver Physiol, 281(2), G526-G532.
19. Poirier H., Mathieu Y. Besnard P., Bernard A. (1997) Comp. Biochem. Physiol. A. Physiol, 116(3), 253-260.
20. Porter C. J., Trevaskis N. L., Charman W. L. (2007) Nat. Rev. Drug Discov, 6(3), 231-248.
21. Dressman J. B., Thelen K., Jantratid E. (2008) Clin. Pharmacokinet, 47(10), 655-667.
22. Keuhoff S., Ungell A. L., Zamora I., Artursson P. (2005) Eur. J. Pharm. Sci, 25(2-3), 211-220.
23. Custodio J. M., Wu C.-Y. Benet L. Z. (2008) Adv. Drug Deliv Rev, 60, 717-733.
24. Pang K. S. (2003) Drug Metab. Dispos, 31(12), 1507-1519.
25. Cao X., Gibbs S. T., Fang L., Miller H. A., Landowski C. P., Shin H. C., Lennernas H., Zhong Y, Amidon G. L., Yu L. X., Sun D. (2006) Pharm. Res, 23(8), 1675-1686.
26. Kim I. W., Booth-Genthe C., Ambudkar S. V. (2008) Mini Rev. Med. Chem, 8(3), 193-200.
27. Agellon L. B., Toth M. J., Thomson A. B. (2002) Mol.Cell Biochem, 239(1-2), 79-82.
28. Besnard P., Niot I., Poirier H, Clément L, Bernard A. (2002) Mol. Cell Biochem, 239(1-2), 139-147.
29. Meunier-Durmort C., Poirier H., Kiot I., Forest C., Besnard P. (1996) Biochem. J., 319(2), 483-487.
30. Trevaskis N. L., Lo C. M., Ma L. Y., Tso P., Irving H. R., Porter C. J., Charman W. N. (2006) Pharm. Res, 23(8), 1786-1796.
31. Wolfrum C. (2007) Cell Mol. Life Sci, 64(19-20), 2465-2476.
32. Tso P., Kauli A, Lo C. M. (2004) Biochem. Soc. Trans, 32(1), 75-78.
33. Kim R. B. (2006) Molecular Pharmaceutics, 3(1), 26-32.
34. Velkov T., Home J., Laguerre A., Jones E., Scanlon M. J., Porter C. J. (2007) Chem. Biol, 14(4), 453-465.
35. Takara K., Ohnishi N., Horibe S., Yokoyama T. (2003) Drug Metab. Dispos, 31(10), 1235-1239.
36. Shayeganpour A., El-Kadi A. O., Brocks D. R. (2006) Drug Metab. Dispos, 34(1), 43-50.
37. Lin J. H., Chiba M., Balani S. K., Chen I. W., Kwei G. Y., Vastag K. J., Kishime J. A. (1996) Drug Metab. Dispos, 24(10), 1111-1120.
38. Behrens D., Fricker R., Bodoky A., Drewe J, Harder F., Heberer M. (1996) J. Pharm. Sci, 85, 666-668.
39. Wasan K. M., Ramaswamy M., Mcintosh M. P., Porter C. J., Charman W. K. (1999) J. Pharm. Sci, 88, 185-190.
40. Kraehenbuhl J.-P., Keutra M. P. (2000) Annu. Res.Cell Dev, 16, 301-332.
41. Florence AT. (1997) Pharm. Res, 14(3), 259-266.
42. Jam'P., Halbert G. W., Language J., Florence A. T. (1990) J. Pharm. Pharmacol, 42(12), 821-826.
43. Salama N. N., Eddington N. D., Fasano A. (2006) Adv. Drug Deliv. Rev, 58(1), 15-28.
44. Lee D. B., Jamgotchian N., Allen S. G., Abeles M. B., Ward H. J. (2008) Am. J. Physiol. Renal Physiol, 295(6), F1601-F612.
45. Kondoh M., Yagi K. (2007) Curr. Med. Chem, 14(23), 2482-2488.
46. Hayashi M., Tomita M. (2007) Drug Metab. Pharmacokinet, 22(2), 67-77.
47. Hussain K., Jaitley V., Florence A. T. (2001) Adv. Drug Deliv. Rev, 50(1-2), 107-142.
48. Florence A. T, Hussain K. (2001 ) Adv. Drug Deliv. Rev, 50, S69-S89.
49. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., Brayden D. (1998) Eur. J. Pharm. Sci, 6(2), 153-163.
50. Florence A. T. (2004) J. Drug Target, 12(2), 65-70.
51. Simovic S., Heard R, Hui H, Song Y, Peddie E, Davey A. K., Lewis A., Rades T, Prestidge C. A. (2009) Mol. Pharm, 6(3), 861-872.
52. Miyazaki S., Yamaguchi H., Yokouchi C., Takada M., Hou W. M. (1988) Chem. Pharm. Bull. (Tokyo), 36(10), 4033-4038.
53. Upadhye A.A., Ambike A.A., Mahadik K. R., Paradkar A. (2008) Drug Dev. Ind. Pharm. 34(10), 1117-1124.
54. Patel A., Modasiya M., Shah D, Patel V. (2009) AAPS Pharm. Sci. Tech, 10(1), 310-315.
55. Sasaki K., Yonebayashi S., Yoshida M., Shimizu K., Aotsuka T., Takayama K. (2003) Int. J. Pharm, 265(1-2), 95-102.
56. Artursson P., Karlsson J. (1991) Biochem. Biophys. Res. Commun, 175, 880-885.
57. Lo Y. L., Huang J. D. (2000) Biochem Pharmacol, 59(6), 665-672.
58. Schmidt P. G., Campbell K. M., Hinds K. D., Cook G. P. (2007) Expert Opin. Biol. Ther, 7(9), 1427-1436.
59. Carrier R. L., Miller L. A., Ahmed I. (2007) J. Control Release, 123(2), 78-99.
60. Croy S. R., Kwon G. S. (2006) Curr. Pharm. Des, 12(36), 4669-4684.
61. Porter C. J., Kaukonen A. M., Boyd B. J., Edwards G. A., Charman W. K. (2004) Pharm. Res, 21, 1405-1412.
62. McConville J. T., Ross A. C., Florence A. J., Stevens H. N. (2005) Drug Dev. Ind. Pharm, 31(1), 79-89.
63. Wiklingm W.I., Prior D. V. (2003) Crit. Rev. Ther. Drug Carrier Syst, 20(6), 405-431.
64. Muller R. H., Keck C. M. (2004) J. Biotechnol, 113(1-3), 151-170.
65. Vyas S. P., Gupta P. N. (2007) Expert Rev. Vaccines, 6(3), 401-418.
66. Hauss D. J. (2007) Adv. Drug Deliv. Rev, 59(7), 667-676.
67. Pouton C. W., Porter C. J. (2008) Adv. Drug Deliv. Rev, 60(6), 625-637.
68. Pouton C. W. (2000) Eur. J. Pharm. Sci, 11, Suppl 2, S93-S98.
69. Gursoy R. K., Benita S. (2004) Biomed. Pharmacother, 58(3), 173-182.
70. Kapitza S. B., Michel B. R., van Hoogevest R, Leigh M. L., Imanidis G. (2007) Eur. J. Pharm. Biopharm, 66(1), 146-158.
71. Porter C. J., Charman S. A., Charman W. N. (1996) J. Pharm. Sci, 85, 351-356.
72. Lacombe O., Woodley J., Solleux C., Delbos J-M, Boursier-Keyret C., Houin G. (2004) Eur. J. Pharmaceutical Sciences, 23, 385-391.